» Articles » PMID: 27540290

A Dual Brain-targeting Curcumin-loaded Polymersomes Ameliorated Cognitive Dysfunction in Intrahippocampal Amyloid-β1-42-injected Mice

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2016 Aug 20
PMID 27540290
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Due to the impermeability of the blood-brain barrier and the nonselective distribution of drugs in the brain, the therapeutic access to intractable neurological disorders is challenging. In this study, dual brain-targeting polymersomes (POs) functionalized by transferrin and Tet-1 peptide (Tf/Tet-1-POs) promoted the transportation of curcumin into the brain and provided neuroprotection. The modification of the ligands that bind to the surface of POs was revealed by X-ray photoelectron spectroscopy analysis. The cell uptake of a coculture model of mouse brain capillary endothelial cells with neurons showed that the Tf/Tet-1-POs had significant transportation properties and possessed affinity for neurons. The pharmacokinetic analysis showed that the blood-brain barrier permeability-surface efficiency of the Tf/Tet-1-POs was 0.28 mL/h/g and that the brain tissue uptake rate (% ID/g) was 0.08, which were significant compared with the controls (P<0.05). The curcumin-encapsulated Tf/Tet-1-POs provided neuroprotection and ameliorated cognitive dysfunction in intrahippocampal amyloid-β1-42-injected mice. These results suggest that the dual brain-targeting POs are more capable of drug delivery to the brain that can be exploited as a multiple noninvasive vehicle for targeting therapeutics.

Citing Articles

Mechanistic insight of curcumin: a potential pharmacological candidate for epilepsy.

Khatoon S, Kalam N Front Pharmacol. 2025; 15():1531288.

PMID: 39845785 PMC: 11752882. DOI: 10.3389/fphar.2024.1531288.


Polymersomes as the Next Attractive Generation of Drug Delivery Systems: Definition, Synthesis and Applications.

Fonseca M, Jarak I, Victor F, Domingues C, Veiga F, Figueiras A Materials (Basel). 2024; 17(2).

PMID: 38255485 PMC: 10817611. DOI: 10.3390/ma17020319.


Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.

Ansari M, Tripathi T, Venkidasamy B, Monziani A, Rajakumar G, Alomary M Mol Neurobiol. 2023; 61(5):3042-3089.

PMID: 37966683 DOI: 10.1007/s12035-023-03730-z.


Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation.

Galindo R, Sanchez-Lopez E, Gomara M, Espina M, Ettcheto M, Cano A Pharmaceutics. 2022; 14(2).

PMID: 35214019 PMC: 8874979. DOI: 10.3390/pharmaceutics14020285.


Action Mechanisms of Curcumin in Alzheimer's Disease and Its Brain Targeted Delivery.

Ege D Materials (Basel). 2021; 14(12).

PMID: 34208692 PMC: 8234049. DOI: 10.3390/ma14123332.


References
1.
Hardy J . The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem. 2009; 110(4):1129-34. DOI: 10.1111/j.1471-4159.2009.06181.x. View

2.
Pak Y, Patek R, Mayersohn M . Sensitive and rapid isocratic liquid chromatography method for the quantitation of curcumin in plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 796(2):339-46. DOI: 10.1016/j.jchromb.2003.08.018. View

3.
Lee H, Kim D, Park S, Kim J, Lee Y, Jung J . Neuroprotective effect of sinapic acid in a mouse model of amyloid β(1-42) protein-induced Alzheimer's disease. Pharmacol Biochem Behav. 2012; 103(2):260-6. DOI: 10.1016/j.pbb.2012.08.015. View

4.
Huwyler J, Wu D, Pardridge W . Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A. 1996; 93(24):14164-9. PMC: 19511. DOI: 10.1073/pnas.93.24.14164. View

5.
Douville N, Tung Y, Li R, Wang J, El-Sayed M, Takayama S . Fabrication of two-layered channel system with embedded electrodes to measure resistance across epithelial and endothelial barriers. Anal Chem. 2010; 82(6):2505-11. PMC: 2839931. DOI: 10.1021/ac9029345. View